A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

On the basis of previous studies showing single-agent efficacy with lenalidomide and panobinostat in patients with relapsed or refractory Hodgkin lymphoma (HL), we conducted a phase I/II study to evaluate the safety and efficacy of the combination in this patient population. The recommended phase II...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Maly, Joseph J., Christian, Beth A., Zhu, Xiaohua, Wei, Lai, Sexton, Jennifer L., Jaglowski, Samantha M., Devine, Steven M., Fehniger, Todd A., Wagner-Johnston, Nina D., Phelps, Mitch A., Bartlett, Nancy L., Blum, Kristie A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033275/
https://ncbi.nlm.nih.gov/pubmed/28622959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2017.05.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados